Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Discontinuation of Infliximab Therapy in Patients With Crohn's Disease During Sustained Complete Remission: A Multi-center, Double Blinded, Randomized, Placebo Controlled Study

NCT01817426 is registered in ClinicalTrials.gov with Copenhagen University Hospital at Herlev as lead sponsor.

NCT NCT01817426
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01817426 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Discontinuation of Infliximab Therapy in Patients With Crohn's Disease During Sustained Complete Remission: A Multi-center, Double Blinded, Randomized, Placebo Controlled Study
Lead sponsor
Copenhagen University Hospital at Herlev
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2013
Completion date
May 31, 2020
Enrollment
115 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

crohn disease